UK Scientists Achieve Breakthrough with First Lab-Grown Oesophagus Implant in Pigs
In a landmark study, researchers from Great Ormond Street Hospital (GOSH) and University College London (UCL) have successfully created and implanted the first lab-grown oesophagus in pigs, enabling the animals to swallow food normally. This pioneering work, published on Friday 20 March 2026 in Nature Biotechnology, represents a significant step toward personalised regenerative therapies for children born with life-threatening oesophageal conditions.
How the Technology Works
The process begins with a scaffold derived from a donor pig's oesophagus, which is structurally similar to a human's. Through decellularisation, all pig cells are removed while preserving the underlying support structure. This scaffold is then repopulated with muscle cells from a recipient pig, taken via a small biopsy and multiplied in a laboratory. The engineered tissue is placed in a bioreactor for one week, where growth fluids circulate to help cells settle and adapt. Overall, the entire procedure takes two months to complete.
Promising Results and Implications
In the study, eight recipient pigs recovered well and developed functional swallowing muscles within three months, with full integration of the engineered tissue. By the six-month mark, the lab-grown grafts had formed working muscles, nerves, and blood vessels, allowing normal contraction and food movement. Notably, immunosuppression was not required because the implants used the recipient's own cells, and the tissue grew alongside the animals. For the first time, spatial transcriptomics was used to map genes in the implanted tissue, confirming that gene activity matched that of natural oesophageal tissue.
Potential Benefits for Children
This technology holds particular promise for children with long-gap oesophageal atresia (LGOA), a rare birth defect where the oesophagus is interrupted by a wide gap. In the UK, approximately 180 babies are born with oesophageal atresia each year, with 10% having LGOA. Currently, these children require complex and invasive surgeries, often involving feeding tubes. The new approach could offer a less invasive alternative, with scaffolds of varying sizes stored for personalised use in newborns or children as needed.
Expert and Parent Perspectives
Aoife Regan, GOSH Charity's director of impact and charitable programmes, expressed enthusiasm, stating that this research offers hope for improving the quality of life for children with complex conditions. Sean, father of two-year-old Casey Mcintyre from London, who has undergone multiple operations, shared his family's experience, highlighting the potential for a single, life-changing procedure to transplant a functional oesophagus early in a child's life.
Future Directions
While previous studies have demonstrated parts of this technology, this is the first to complete the full process with such success. The encouraging results from pig research provide a blueprint for human applications, potentially paving the way for treatments in other disease areas. Scientists aim to adapt this technology for clinical use, offering new hope for regenerative medicine and personalised healthcare solutions.
